Major biochemical markers that act as predictors severity in patients with severe preeclampsia in ages 18 and 26 in the Niño Jesús Hospital of Barranquilla, 2014-2015

Authors

  • Leonardo Fabio Salgado Universidad Libre
  • Kevin Alberto García Fontalvo Universidad Libre Seccional Barranquilla

DOI:

https://doi.org/10.18041/2390-0512/bioc..2.2639

Keywords:

Pre-eclampsia, Toxemic profile, Eclampsia, Severity, Hypertension and marker

Abstract

The objective of this research was to determine which of the major biochemical markers that are part of the profile toxemic have greater association with severe pre-eclampsia in patients aged between 18 and 26 years in the Niño Jesus Hospital of Barranquilla in the period December 2014 to May 2015, is a retrospective descriptive correlational study; in this study 120 medical records of pregnant women who consulted in the Niño Jesus Hospital of Barranquilla which had pre-eclampsia in the aforementioned period were reviewed, they were classified by groups: Those that remained with a diagnosis of pre-eclampsia and patients that ended in severe pre-eclampsia. The variables analyzed were age, gestational age, blood pressure, risk factors and the development of preeclampsia, results toxemic profile (creatinine, LDH, transaminases, platelets, total, direct and indirect bilirubin, proteinuria random and within 24 hours). Toxemic profile components that had a close relationship with severe pre-eclampsia were the LDH (OR 3.35, 95% CI 0.41-26.84), platelets (OR 0.17 95% CI 0.028-1.08) and random proteinuria (OR 0.81 95% CI 0.16 -4.04). Given the general characteristics of pregnant women with severe pre-eclampsia study population the average age at presentation was 21.6 years appearing more frequently in patients aged between 18 and 20 years, most of these pregnant women in their first pregnancy (gilts); likewise the median gestational age at presentation was 36.5 weeks, with the largest group affected with gestational age between 35 and 39.6 weeks gestation, terminating pregnancy mostly surgically (cesarean). The most frequent risk factor was a family history of hypertension.

Downloads

Download data is not yet available.

References

1. Hypertension in pregnancy: The manage-ment of hypertensive disorders during preg-nancy, NICE clinical guideline 107; August 2010.

2. Say D, Alison O, Ann-Beth M, Jane D, Metin G, Marleen T, et al. Global causes of maternal death: a WHO systematic analysis Lale. Lan-cet Glob Health 2014; 2:e323-33.

3. Determinantes sociales de la morbilidad y la mortalidad maternas. Acciones para superar las demoras I y II; UNFPA, Minsalud. Bogotá; 2014.

4. Objetivos de desarrollo del milenio, Colombia 2014, Programa de las Naciones Unidas para el Desarrollo (PNUD); 2014.

5. Protocolo de vigilancia en salud pública: Morbilidad extrema, Instituto Nacional de Salud, 19 mayo de 2015.

6. Cifuentes R. Obstetricia de alto riesgo, 6ta. edición, Distribuna Editorial Médica; 2006.

7. Beth P, Magee L, Dadelszen P. Assessment, surveillance and prognosis in preeclampsia. Best Practice & Research Clinical Obstetrics and Gynaecology. 2011; 25:449-62.

8. Von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Cote AM, Douglas MJ et al. Prediction of adverse maternal outcomes in pre-eclampsia: Development and valida-tion of the fullPIERS model. Lancet. 2011; 377: 219-27.

9. Freitas LG, Alpoim PN, Komatsuzaki F, Carval-ho MD, Dusse LM. Pre-eclampsia: are plate-let count and indices useful for its prognos-tic. Hematology. 2013; 18(6):360-4.

10. Muller-Deie J, Schiffer M. Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy. World Jour-nal of Nephrology. 2014; 3(4):169-81.

11. Thornton CE, Makris A, Ogle RF, Tooher JM, Hennessy A. Role of proteinuria in defining pre-eclampsia: Clinical outcomes for wo-men and babies. Clin Exp Pharmacol Physiol. 2010; 37(4):466-70.

Downloads

Published

2015-08-12

Issue

Section

ARTICLE OF SCIENTIFIC AND TECHNOLOGICAL RESEARCH

How to Cite

Major biochemical markers that act as predictors severity in patients with severe preeclampsia in ages 18 and 26 in the Niño Jesús Hospital of Barranquilla, 2014-2015. (2015). Biociencias, 10(2), 29-36. https://doi.org/10.18041/2390-0512/bioc..2.2639